SCHEMBL3763752

SCHEMBL3763752

Cn1cnc(CNC(=O)c2cccc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.39
HDAC1 Q13547 3/20 0.39
JAK2 O60674 1/20 0.36
KMT2A Q03164 1/20 0.36
EGLN2 Q96KS0 1/20 0.36
HPGDS O60760 1/20 0.35
SCN9A Q15858 1/20 0.34
STK4 Q13043 1/20 0.34
STK3 Q13188 1/20 0.34
LRRK2 Q5S007 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
POLB P06746 1/20 0.34
ROCK2 O75116 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
NAMPT P43490 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762309 0.89 PIK3CA (0.39) ALDH1A1NAMPTPIK3CDPIK3CAPIK3CG
SCHEMBL3761666 0.89 KMT2A (0.48) KDM1AHDAC1KMT2ASCN9AALDH1A1
SCHEMBL3764646 0.87 MAPK1 (0.47) KDM1AHDAC1JAK2SCN9AALDH1A1
SCHEMBL3765560 0.87 BUB1 (0.40) KDM1AHDAC1JAK2SCN9AALDH1A1
SCHEMBL3762516 0.86 MEN1 (0.46) KDM1AHDAC1KMT2AMAPTROCK2
SCHEMBL3759936 0.85 CYP2C19 (0.49) POLB
SCHEMBL3769319 0.85 MAPT (0.48) KDM1AHDAC1KMT2AMAPTROCK2
SCHEMBL3759012 0.84 JAK2 (0.47) KDM1AHDAC1JAK2SCN9AROCK2
SCHEMBL3757673 0.84 PIK3CA (0.41) SCN9AMAPTPIK3CDPIK3CAPIK3CB
SCHEMBL3761437 0.82 PRMT5 (0.41) ALDH1A1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA KDM1A 3543/4885HDAC1 669/4885JAK2 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.